LIVEBETTER (a trial comparing the effectiveness and tolerability of medications in older adults with stable angina and multiple chronic conditions)
Volunteers
Health Professionals
What is the purpose of this trial?
The purpose of the LIVEBETTER study is to learn how older patients with heart disease tolerate the two primary medication groups that are currently available to treat symptoms of angina. The study will compare how Beta-Blocker and Calcium Channel Blocker medications work to improve patients’ symptoms and overall quality of life. People who participate will be randomly assigned to one of these two groups of medications, and they will be followed for one year with interviews and a short walk assessment.
Contact information:
Michael G. Nanna, MD, MHS, FSCAI, FACC
Section of Cardiovascular Medicine
Yale School of Medicine
Email: livebetter-trial@yale.edu
Toll-Free: (888) 683-0865 – please state you are calling about the LIVEBETTER heart study.
Help Us Discover!
You can help our team find trials you might be eligible for by creating a volunteer profile in MyChart. To get started, create a volunteer profile, or contact helpusdiscover@yale.edu, or call 877.978.8343 for more information.
Principal Investigator
Sub-Investigators
- Last Updated05/03/2024
- Study HIC#2000034470